Research identifies potential to improve lung cancer survival rates through therapy choices
While Immune Checkpoint Inhibitor (ICI) immunotherapy drugs have transformed the treatment of many cancers, some lung cancer patients experience hyperprogression—a paradoxical rapid acceleration of tumor growth—after ...
Apr 28, 2023
0
13